Viemed Healthcare Ratios (2018-2025) | VMD

Ratios Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 74.51%72.48%75.78%73.62%72.17%72.02%68.98%66.41%65.33%60.50%58.16%61.46%62.44%64.33%62.77%61.52%61.21%61.21%60.55%61.04%60.68%60.28%61.86%63.29%58.91%59.84%59.26%59.54%56.28%58.25%57.49%
EBT Margin 15.92%13.80%13.31%16.85%11.57%6.64%14.26%11.40%18.61%29.79%11.79%16.74%5.14%10.26%10.84%15.82%7.77%4.17%4.23%9.56%5.10%7.06%8.58%10.00%4.19%4.08%9.48%10.39%6.19%7.87%7.14%
EBIT Margin 16.77%15.04%14.83%15.87%12.78%8.19%10.73%12.55%19.39%30.01%12.08%16.88%4.69%9.72%9.97%14.60%6.97%3.01%4.11%9.42%4.89%6.70%8.51%10.42%4.36%6.58%9.70%10.63%6.50%8.08%7.85%
EBITDA Margin 18.25%15.56%14.32%12.94%10.81%5.80%13.58%11.50%16.51%45.22%8.46%16.34%6.30%5.69%6.18%12.95%5.97%3.08%3.26%6.35%3.84%5.38%5.91%6.85%3.17%6.58%9.70%10.63%6.50%8.08%7.85%
Operating Margin 16.77%15.04%14.83%15.87%12.78%8.19%10.73%12.55%19.39%30.01%12.08%16.88%4.69%9.72%9.97%14.60%6.97%3.01%4.11%9.42%4.89%6.70%8.51%10.42%4.36%6.58%9.70%10.63%6.50%8.08%7.85%
Net Margin 15.92%13.80%13.11%16.16%10.81%6.52%14.01%11.13%17.82%45.30%8.38%16.25%5.93%5.72%6.11%12.79%5.46%2.90%2.95%6.50%3.84%5.38%5.91%6.85%3.17%2.69%6.73%7.29%4.50%5.15%5.01%
FCF Margin 21.52%30.85%2.95%-11.17%13.95%21.43%-15.18%46.37%14.52%3.05%9.96%3.41%-10.26%6.23%9.87%-6.24%4.57%5.63%14.70%3.57%12.97%10.55%-9.55%2.27%3.00%5.20%-21.36%6.54%14.92%
Efficiency
Inventory Average 1.95M2.16M2.63M3.25M3.66M2.49M1.31M1.57M4.18M4.67M2.54M2.27M2.39M2.59M2.54M2.48M2.68M3.02M3.38M3.51M3.96M4.57M4.65M4.49M4.39M4.37M4.32M4.42M4.42M4.80M
Assets Average 42.46M46.75M51.45M56.19M64.87M75.50M81.29M84.70M99.49M113.07M113.26M112.78M112.01M113.25M116.72M118.48M117.46M117.66M118.23M120.84M136.88M149.26M152.15M154.88M159.41M166.74M173.30M177.57M181.34M193.48M
Equity Average 26.12M28.95M31.48M33.23M35.01M38.23M42.01M46.25M59.96M73.16M78.45M82.56M84.84M87.82M92.10M95.43M94.64M93.57M95.50M98.57M102.27M106.66M111.35M115.08M118.73M123.99M130.05M135.03M139.19M138.56M
Invested Capital 24.74M27.50M30.39M32.57M33.89M40.97M50.13M53.08M57.75M79.64M83.27M89.33M90.60M92.99M95.63M100.61M101.36M98.06M94.07M97.09M100.04M104.61M108.91M114.97M116.87M121.95M127.61M133.71M137.14M142.44M137.05M
Asset Utilization Ratio 1.251.221.141.020.991.011.091.081.161.211.081.031.001.021.081.131.171.211.141.141.201.251.291.291.291.311.331.32
Leverage & Solvency
Debt to Equity 0.130.240.210.180.120.110.090.090.080.070.060.060.050.050.150.090.060.060.080.040.030.030.030.16
Debt Ratio 0.070.120.110.100.080.070.070.060.060.050.050.040.040.040.100.070.050.040.060.030.020.020.020.10
Equity Ratio 0.610.620.620.610.580.510.500.530.560.630.660.730.740.780.770.800.810.800.790.830.800.700.730.740.750.740.750.750.770.770.67
Dividends & Payouts
FCF Payout Ratio 0.010.01
Valuation
Enterprise Value -4.63M-8.55M-10.17M-10.41M-7.41M-7.69M-12.63M-13.36M-8.41M-29.71M-32.40M-30.98M-31.10M-31.15M-26.87M-28.41M-29.25M-21.92M-21.48M-16.91M-23.54M-10.22M-10.08M-12.84M-7.31M-7.00M-9.51M-15.63M-8.17M-18.12M-9.24M
Return Ratios
Return on Sales 0.16%0.14%0.13%0.16%0.11%0.07%0.14%0.11%0.18%0.45%0.08%0.16%0.06%0.06%0.06%0.13%0.05%0.03%0.03%0.06%0.04%0.05%0.06%0.07%0.03%0.03%0.07%0.07%0.05%0.05%0.05%
Return on Capital Employed 0.32%0.29%0.25%0.19%0.16%0.19%0.33%0.29%0.30%0.26%0.14%0.13%0.12%0.12%0.11%0.10%0.08%0.08%0.09%0.11%0.12%0.12%0.12%0.13%0.13%0.14%0.15%0.14%
Return on Invested Capital 0.31%0.29%0.24%0.19%0.17%0.20%0.42%0.36%0.37%0.32%0.12%0.10%0.09%0.08%0.08%0.07%0.06%0.06%0.07%0.08%0.09%0.09%0.09%0.09%0.10%0.10%0.10%0.10%
Return on Assets 0.18%0.16%0.13%0.12%0.10%0.13%0.29%0.26%0.28%0.26%0.10%0.09%0.08%0.08%0.07%0.07%0.05%0.05%0.05%0.06%0.07%0.07%0.06%0.06%0.07%0.07%0.08%0.07%
Return on Equity 0.30%0.28%0.24%0.24%0.20%0.23%0.48%0.39%0.40%0.35%0.13%0.12%0.10%0.10%0.09%0.08%0.07%0.06%0.07%0.09%0.09%0.09%0.08%0.08%0.09%0.09%0.10%0.10%